Global Cell Line Development Market Size study, by Type (Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines), by Product (Equipment, Media and Reagents), by Source (Mammalians) and Regional Forecasts 2021-2027
- BIZ4899761
- 200 Pages
- January 2022
- Pharmaceuticals
The key regions considered for the global Cell Line Development market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to increased demand for monoclonal antibodies, rising vaccine production, and the use of innovative technologies. Whereas, North-America is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as increasing demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies would create lucrative growth prospects for the Cell Line Development market across North America region.
Major market players included in this report are:
Sartorius AG (Germany)
American Type Culture Collection (ATCC) (U.S.)
Lonza Group AG (Switzerland)
Thermo Fisher Scientific, Inc. (U.S.)
GE Healthcare (U.K.)
Sigma Aldrich Corporation (U.S.)
Selexis SA (Switzerland)
European Collection of Cell Cultures (ECACC) (U.K.)
Corning, Inc. (U.S.)
Wuxi App Tec, Inc. (China)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Primary Cell Lines
Continuous Cell Lines
Hybridomas
Recombinant Cell Lines
By Product:
Equipment
Media and Reagents
By Source:
Mammalians
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Cell Line Development Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Global Cell Line Development Market, by Region, 2019-2027 (USD Billion)
1.2.2. Global Cell Line Development Market, by Type, 2019-2027 (USD Billion)
1.2.3. Global Cell Line Development Market, by Product, 2019-2027 (USD Billion)
1.2.4. Global Cell Line Development Market, by Source, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell Line Development Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell Line Development Market Dynamics
3.1. Cell Line Development Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for monoclonal antibodies
3.1.1.2. Increasing investment in hospital infrastructure
3.1.2. Market Challenges
3.1.2.1. Developing Stable and Authentic Cell Lines
3.1.3. Market Opportunities
3.1.3.1. Increasing risk of pandemic and communicable diseases
Chapter 4. Global Cell Line Development Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Cell Line Development Market, by Type
6.1. Market Snapshot
6.2. Global Cell Line Development Market by Type, Performance – Potential Analysis
6.3. Global Cell Line Development Market Estimates & Forecasts by Type, 2018-2027 (USD Billion)
6.4. Cell Line Development Market, Sub Segment Analysis
6.4.1. Primary Cell Lines
6.4.2. Continuous Cell Lines
6.4.3. Hybridomas
6.4.4. Recombinant Cell Lines
Chapter 7. Global Cell Line Development Market, by Product
7.1. Market Snapshot
7.2. Global Cell Line Development Market by Product, Performance - Potential Analysis
7.3. Global Cell Line Development Market Estimates & Forecasts by Product, 2018-2027 (USD Billion)
7.4. Cell Line Development Market, Sub Segment Analysis
7.4.1. Equipment
7.4.2. Media and Reagents
Chapter 8. Global Cell Line Development Market, by Source
8.1. Market Snapshot
8.2. Global Cell Line Development Market by Source, Performance - Potential Analysis
8.3. Global Cell Line Development Market Estimates & Forecasts by Source, 2018-2027 (USD Billion)
8.4. Cell Line Development Market, Sub Segment Analysis
8.4.1. Mammalians
Chapter 9. Global Cell Line Development Market, Regional Analysis
9.1. Cell Line Development Market, Regional Market Snapshot
9.2. North America Cell Line Development Market
9.2.1. U.S. Cell Line Development Market
9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Product breakdown estimates & forecasts, 2018-2027
9.2.1.3. Source breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Cell Line Development Market
9.3. Europe Cell Line Development Market Snapshot
9.3.1. U.K. Cell Line Development Market
9.3.2. Germany Cell Line Development Market
9.3.3. France Cell Line Development Market
9.3.4. Spain Cell Line Development Market
9.3.5. Italy Cell Line Development Market
9.3.6. Rest of Europe Cell Line Development Market
9.4. Asia-Pacific Cell Line Development Market Snapshot
9.4.1. China Cell Line Development Market
9.4.2. India Cell Line Development Market
9.4.3. Japan Cell Line Development Market
9.4.4. Australia Cell Line Development Market
9.4.5. South Korea Cell Line Development Market
9.4.6. Rest of Asia Pacific Cell Line Development Market
9.5. Latin America Cell Line Development Market Snapshot
9.5.1. Brazil Cell Line Development Market
9.5.2. Mexico Cell Line Development Market
9.6. Rest of The World Cell Line Development Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Sartorius AG (Germany)
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. American Type Culture Collection (ATCC) (U.S.)
10.2.3. Lonza Group AG (Switzerland)
10.2.4. Thermo Fisher Scientific, Inc. (U.S.)
10.2.5. GE Healthcare (U.K.)
10.2.6. Sigma Aldrich Corporation (U.S.)
10.2.7. Selexis SA (Switzerland)
10.2.8. European Collection of Cell Cultures (ECACC) (U.K.)
10.2.9. Corning, Inc. (U.S.)
10.2.10. Wuxi App Tec, Inc. (China)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
TABLE 1. Global Cell Line Development market, report scope
TABLE 2. Global Cell Line Development market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Cell Line Development market estimates & forecasts by Type 2018-2027 (USD Billion)
TABLE 4. Global Cell Line Development market estimates & forecasts by Product 2018-2027 (USD Billion)
TABLE 5. Global Cell Line Development market estimates & forecasts by Source 2018-2027 (USD Billion)
TABLE 6. Global Cell Line Development market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Cell Line Development market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Cell Line Development market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Cell Line Development market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Cell Line Development market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Cell Line Development market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Cell Line Development market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Cell Line Development market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Cell Line Development market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Cell Line Development market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row Cell Line Development market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row Cell Line Development market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Cell Line Development market
TABLE 56. List of primary sources, used in the study of global Cell Line Development market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
